"Long term" debt is usually a no-op for development stage biotech. Having said that, shortly PPS of BIOD will overtake PPS of MNKD. There is no comparison between these two. Inhaled insulin is a failed administration technique. Irrespective of whether someone likes or dislikes BIOD, investing in MNKD is throwing away money.